Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Ponziani
Observed names:
Ponziani, Sara,
S. Ponziani,
Sara PONZIANI
Institution:
University of L'Aquila
Observed institution:
University of L'Aquila
ORCID:
0000-0002-3030-8837
Observed ORCID:
0000-0002-3030-8837
OpenAlex ID:
A5031961915
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
2020
·
Sara Ponziani
, Giulia Di Vittorio
, et al.
·
International Journal of Molecular Sciences
·
206
PDF
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates
2018
·
Francesco Giansanti
, Emily Capone
, et al.
·
Journal of Controlled Release
·
46
PDF
Extracellular LGALS3BP : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
2023
·
Beatrice Dufrusine
, Emily Capone
, et al.
·
Molecular Oncology
·
41
PDF
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
2020
·
Emily Capone
, Alessia Lamolinara
, et al.
·
Cancers
·
38
PDF
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma
2017
·
Emily Capone
, Francesco Giansanti
, et al.
·
Oncotarget
·
30
PDF
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer
2020
·
Daniela D'Agostino
, Roberta Gentile
, et al.
·
Oncology Reports
·
15
PDF
Characterization of two 1,3-β-glucan-modifying enzymes from Penicillium sumatraense reveals new insights into 1,3-β-glucan metabolism of fungal saprotrophs
2022
·
Valentina Scafati
, Francesca Troilo
, et al.
·
Biotechnology for Biofuels and Bioproducts
·
12
PDF
Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells
2021
·
Luana di Leandro
, Francesco Giansanti
, et al.
·
Frontiers in Pharmacology
·
12
PDF
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate
2024
·
Sandra Bibbò
, Emily Capone
, et al.
·
Journal of Controlled Release
·
10
Abstract 238: Therapeutic activity of the non-internalizing antibody drug conjugate 1959-sss/DM3 targeting galectin3-binding protein in human neuroblastoma
2019
·
Emily Capone
, Sara Ponziani
, et al.
·
Cancer Research
·
1
Abstract 748: Non-internalizing site-specific antibody-drug conjugates based on maytansinoids display curative properties
2018
·
Gianluca Sala
, Emily Capone
, et al.
·
Cancer Research
·
1
05 | Attività antitrombotica di peptidi derivati dal latte: caratterizzazione di campioni di latte digerito e valorizzazione del prodotto (latte addizionato)
2026
·
M. Colasante
, M. Catanesi
, et al.
·
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
Author response for "Extracellular LGALS3BP : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma"
2023
·
Beatrice Dufrusine
, Emily Capone
, et al.
·
Publons reviews and discussion
Author response for "Extracellular LGALS3BP : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma"
2023
·
Beatrice Dufrusine
, Emily Capone
, et al.
·
Publons reviews and discussion
Abstract 238: Therapeutic activity of the non-internalizing antibody drug conjugate 1959-sss/DM3 targeting galectin3-binding protein in human neuroblastoma
2019
·
Emily Capone
, Sara Ponziani
, et al.
·
Experimental and Molecular Therapeutics
Abstract 41: An Antibody Drug Conjugate targeting HER-3 demonstrates promising antitumor efficacy in a wide range of human cancer
2017
·
Gianluca Sala
, Manuela Iezzi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
20
Citation count:
412
H-index:
9
I10-index:
9
Year
Topic
Type